NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 8 of 24
Telehealth BPT in DBP Practice
NCT05301933
Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery
NCT05925426
Presence or Absence of Blood in the GI Lumen
NCT05415124
RELAXaHEAD for Headache Patients (Phase II)
NCT05466682
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT04960384
Measuring Pharyngeal Muscle Improvements Following Behavioral Swallowing Exercises
NCT05080725
Pilot Subsidized and Culturally-adapted Community Supported Agriculture (CSA) Program
NCT06521411
taVNS on Pupillary Response and Perceptual Learning
NCT05386563
A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes
NCT05219474
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)
NCT05275920
Peers and Technology for Adherence, Access, Accountability, and Analytics
NCT05051124
The Using Postoperative Ketamine and Exploring the Effect on Endometriosis Pain (UPKEEEP) Study
NCT05229653
Addressing Health Disparities in Chronic Low Back Pain With Patient-Clinician Relatedness
NCT05580380
A Pilot Study to Test the Feasibility of a Hybrid Preoperative Physical Therapy Intervention for Patients Undergoing Total Joint Arthroplasty
NCT05286515
A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation
NCT04682509
Influence of Social Media Ads on Food Choice
NCT05380505
Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study
NCT05203926
Sound Conduction of Infant Hips
NCT05188235
Examining the Impact of Family Connectors
NCT05195489
Peer Education as a Strategy to Promote Vaccine Acceptance
NCT05875779
Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support
NCT04255303
Induction Optimization With Stelara for Crohn's Disease
NCT04629196
Adherence Connection for Counseling, Education, and Support (ACCESS) II
NCT04499781
WeChat Quit Coach Pilot Study
NCT05130788
Cognitive Markers in Prodromal MS
NCT05543915
Video Interaction Project in Brazil
NCT05198739
CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)
NCT04760613
Integrated Palliative Care With Nephrology Care
NCT04998110
PiPT in ADSM With MSD
NCT05132400
A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression
NCT05188248
A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)
NCT05152615
Treatment for Migraine and Mood (Team-M)
NCT04992494
Body Weight, Aspirin Dose and Pro-resolving Mediators
NCT04697719
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
NCT05172024
A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training
NCT05135195
Impact of Behavioral Economic Strategies on Low-Income Older Adults' Food Choices in Online Retail Settings
NCT04766034
Electronic Triggers: Microhematuria Trigger
NCT05011253
Synovial Fluid Sleep Study
NCT04688099
Adherence in Upper Extremity Home-based Rehabilitation
NCT05032638
Computer Screen Properties Study
NCT05042960
Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice
NCT04713033
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
NCT05077293
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
NCT04544475
Targeting Hyaluronan Accumulation Through Exercise in T2DM
NCT04383314
Randomized Trial of Trust in Online Videos About Prostate Cancer
NCT05886751
COVID-19 Serologic Strategies for Skilled Nursing Facilities
NCT05270980
Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults
NCT04640766
Comparison of Bracing With Co-aptation Splinting for the Initial Treatment of Acute Humeral Shaft Fractures: The COBRAS Trials
NCT05118087
PAVS in Cardiology
NCT04656132
Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis
NCT04867369
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.